| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | SVP, Clinical Development
1 company
Mellion Michelle L is a Chief Medical Officer at PEPG. Recent filings cover 0 purchases and 12 sales. Those positions are worth an estimated $77K at current prices.
Our model assigns Mellion Michelle L a strong insider score of 96/100, based on 12 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +92.2%.
Mellion Michelle L's largest disclosed position is in PEPG as Chief Medical Officer, worth about $77K. The recent filings there lean toward selling, a net 50,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 25, 2024 | PEPG Pepgen Inc. | Chief Medical Officer | Sale+OE | 7,772 | $18.06 | $140,360.37 | -100% | -51.7% | -92.0% | |
| Jul 18, 2024 | PEPG Pepgen Inc. | Chief Medical Officer | Sale+OE | 12,625 | $18.20 | $229,804.04 | -100% | -45.9% | -91.9% | |
| Jul 16, 2024 | PEPG Pepgen Inc. | Chief Medical Officer | Sale+OE | 9,189 | $18.02 | $165,578.22 | -100% | -51.4% | -92.9% | |
| Jul 2, 2024 | PEPG Pepgen Inc. | Chief Medical Officer | Sale+OE | 912 | $18.01 | $16,428.22 | -100% | -47.6% | -92.6% | |
| Jun 24, 2024 | PEPG Pepgen Inc. | Chief Medical Officer | Sale+OE | 9,260 | $18.19 | $168,427.36 | -100% | -49.7% | -92.2% | |
| Jun 12, 2024 | PEPG Pepgen Inc. | Chief Medical Officer | Sale+OE | 1,586 | $18.06 | $28,636.68 | -100% | -50.9% | -91.7% | |
| Jun 6, 2024 | PEPG Pepgen Inc. | SVP, Clinical Development | Sale+OE | 8,656 | $18.08 | $156,460.05 | -100% | -47.5% | -91.3% |